Stocks rise over Pfizer’s Covid vaccine

THE rally in global equities extended Tuesday, a day after Pfizer said its late-stage trial of its Covid-19 vaccine had shown promising results, but caution over the depth of the coronavirus pandemic and an uncertain US political climate limited gain. Futures tied to the Dow Jones Industrial Average, the S&P 500, and the Nasdaq rose…

Subscribe to read full article. Subscribe today

Related posts

Southern Africa payments hub eyes more currencies to boost trade

African central banks set to hold rates as inflation fears grow

ECOWAS nations sign landmark agreement on Nigeria-Morocco gas pipeline

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Read More